Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Net Income (2016 - 2025)

Bio-Techne has reported Net Income over the past 17 years, most recently at $38.0 million for Q4 2025.

  • Quarterly results put Net Income at $38.0 million for Q4 2025, up 8.94% from a year ago — trailing twelve months through Dec 2025 was -$5.7 million (down 103.88% YoY), and the annual figure for FY2025 was -$13.4 million, down 108.53%.
  • Net Income for Q4 2025 was $38.0 million at Bio-Techne, roughly flat from $38.2 million in the prior quarter.
  • Over the last five years, Net Income for TECH hit a ceiling of $89.7 million in Q3 2022 and a floor of -$193.2 million in Q2 2022.
  • Median Net Income over the past 5 years was $41.8 million (2021), compared with a mean of $23.2 million.
  • Biggest five-year swings in Net Income: soared 123.65% in 2023 and later crashed 451.77% in 2025.
  • Bio-Techne's Net Income stood at $72.1 million in 2021, then plummeted by 30.61% to $50.0 million in 2022, then crashed by 45.08% to $27.5 million in 2023, then rose by 27.03% to $34.9 million in 2024, then rose by 8.94% to $38.0 million in 2025.
  • The last three reported values for Net Income were $38.0 million (Q4 2025), $38.2 million (Q3 2025), and -$104.5 million (Q2 2025) per Business Quant data.